JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.8 CNY | -1.22% |
|
-5.68% | +26.36% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd a China-based company principally engaged in the independent research and development and customized research and development and production of peptide drugs and small molecule drugs. The Company's main business includes customized product business and independently selected product business. Its customized product business includes CDMO (Contract Development and Manufacturing Organization) business, technical service CRO (Contract Research Organization) and transfer business. Its independently selected product business focuses on small molecule chemical drugs and conducts drug research and development in the key treatment areas of diabetes, cardiovascular diseases, tumors and other diseases. The Company mainly operates its businesses in the domestic market and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
56.8
CNY
Average target price
62.24
CNY
Spread / Average Target
+9.59%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +26.36% | 1.7B | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- 688076 Stock
- News Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
- Sinopep-Allsino Biopharma Unit to Buy 9% Stake in Biotech Firm
